Aprogen Biologics Inc. (KRX:003060)
359.00
-49.00 (-12.01%)
At close: Feb 25, 2026
-55.68% (1Y)
| Market Cap | 70.93B -53.4% |
| Revenue (ttm) | 74.91B +10.1% |
| Net Income | -194.29B |
| EPS | -983.23 |
| Shares Out | 197.57M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,075,170 |
| Average Volume | 3,851,148 |
| Open | 408.00 |
| Previous Close | 408.00 |
| Day's Range | 357.00 - 457.00 |
| 52-Week Range | 287.00 - 840.00 |
| Beta | -0.03 |
| RSI | 35.94 |
| Earnings Date | Mar 16, 2026 |